Global Anti-Diabetic Drugs Market Research Report 2023

The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for diabetes have become the focal point of attention due to the burgeoning diabetic population size, with diabetes affecting middle age groups and children across all income groups globally.

The global Anti-Diabetic Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Some of the major drivers and opportunities for growth of this market include drug combinations of several agents such as sitagliptin and metformin and other drug combinations that are in different stages of clinical and pipeline development. Increase in the prevalence of diabetes and new product launches by major pharmaceutical companies re some of the key drivers for growth in this market. In 2015, Boehringer Ingelheim GmbH launched two new drugs (Synjardy & Glyxambi)for treatment of diabetes mellitus type II. 

This report aims to provide a comprehensive presentation of the global market for Anti-Diabetic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Diabetic Drugs.

The Anti-Diabetic Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Anti-Diabetic Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anti-Diabetic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Anti-Diabetic Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Biguanides

1.2.3 Sulfonylureas

1.2.4 Meglitinides

1.2.5 Thiazolidinediones

1.2.6 Dipeptidyl Peptidase IV Inhibitors

1.2.7 α-Glucosidase Inhibitors

1.3 Market by Application

1.3.1 Global Anti-Diabetic Drugs Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Type I Diabetes

1.3.3 Type II Diabetes

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Anti-Diabetic Drugs Market Perspective (2018-2029)

2.2 Anti-Diabetic Drugs Growth Trends by Region

2.2.1 Global Anti-Diabetic Drugs Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Anti-Diabetic Drugs Historic Market Size by Region (2018-2023)

2.2.3 Anti-Diabetic Drugs Forecasted Market Size by Region (2024-2029)

2.3 Anti-Diabetic Drugs Market Dynamics

2.3.1 Anti-Diabetic Drugs Industry Trends

2.3.2 Anti-Diabetic Drugs Market Drivers

2.3.3 Anti-Diabetic Drugs Market Challenges

2.3.4 Anti-Diabetic Drugs Market Restraints

3.1 Global Top Anti-Diabetic Drugs Players by Revenue

3.1.1 Global Top Anti-Diabetic Drugs Players by Revenue (2018-2023)

3.1.2 Global Anti-Diabetic Drugs Revenue Market Share by Players (2018-2023)

3.2 Global Anti-Diabetic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Anti-Diabetic Drugs Revenue

3.4 Global Anti-Diabetic Drugs Market Concentration Ratio

3.4.1 Global Anti-Diabetic Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Anti-Diabetic Drugs Revenue in 2022

3.5 Anti-Diabetic Drugs Key Players Head office and Area Served

3.6 Key Players Anti-Diabetic Drugs Product Solution and Service

3.7 Date of Enter into Anti-Diabetic Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Anti-Diabetic Drugs Historic Market Size by Type (2018-2023)

4.2 Global Anti-Diabetic Drugs Forecasted Market Size by Type (2024-2029)

5.1 Global Anti-Diabetic Drugs Historic Market Size by Application (2018-2023)

5.2 Global Anti-Diabetic Drugs Forecasted Market Size by Application (2024-2029)

6.1 North America Anti-Diabetic Drugs Market Size (2018-2029)

6.2 North America Anti-Diabetic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Anti-Diabetic Drugs Market Size by Country (2018-2023)

6.4 North America Anti-Diabetic Drugs Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Anti-Diabetic Drugs Market Size (2018-2029)

7.2 Europe Anti-Diabetic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Anti-Diabetic Drugs Market Size by Country (2018-2023)

7.4 Europe Anti-Diabetic Drugs Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Anti-Diabetic Drugs Market Size (2018-2029)

8.2 Asia-Pacific Anti-Diabetic Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Anti-Diabetic Drugs Market Size by Region (2018-2023)

8.4 Asia-Pacific Anti-Diabetic Drugs Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Anti-Diabetic Drugs Market Size (2018-2029)

9.2 Latin America Anti-Diabetic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Anti-Diabetic Drugs Market Size by Country (2018-2023)

9.4 Latin America Anti-Diabetic Drugs Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Anti-Diabetic Drugs Market Size (2018-2029)

10.2 Middle East & Africa Anti-Diabetic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Anti-Diabetic Drugs Market Size by Country (2018-2023)

10.4 Middle East & Africa Anti-Diabetic Drugs Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Astra Zeneca

11.1.1 Astra Zeneca Company Detail

11.1.2 Astra Zeneca Business Overview

11.1.3 Astra Zeneca Anti-Diabetic Drugs Introduction

11.1.4 Astra Zeneca Revenue in Anti-Diabetic Drugs Business (2018-2023)

11.1.5 Astra Zeneca Recent Development

11.2 Boehringer Ingelheim

11.2.1 Boehringer Ingelheim Company Detail

11.2.2 Boehringer Ingelheim Business Overview

11.2.3 Boehringer Ingelheim Anti-Diabetic Drugs Introduction

11.2.4 Boehringer Ingelheim Revenue in Anti-Diabetic Drugs Business (2018-2023)

11.2.5 Boehringer Ingelheim Recent Development

11.3 Eli Lilly

11.3.1 Eli Lilly Company Detail

11.3.2 Eli Lilly Business Overview

11.3.3 Eli Lilly Anti-Diabetic Drugs Introduction

11.3.4 Eli Lilly Revenue in Anti-Diabetic Drugs Business (2018-2023)

11.3.5 Eli Lilly Recent Development

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Detail

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Anti-Diabetic Drugs Introduction

11.4.4 Johnson & Johnson Revenue in Anti-Diabetic Drugs Business (2018-2023)

11.4.5 Johnson & Johnson Recent Development

11.5 Merck

11.5.1 Merck Company Detail

11.5.2 Merck Business Overview

11.5.3 Merck Anti-Diabetic Drugs Introduction

11.5.4 Merck Revenue in Anti-Diabetic Drugs Business (2018-2023)

11.5.5 Merck Recent Development

11.6 Novartis

11.6.1 Novartis Company Detail

11.6.2 Novartis Business Overview

11.6.3 Novartis Anti-Diabetic Drugs Introduction

11.6.4 Novartis Revenue in Anti-Diabetic Drugs Business (2018-2023)

11.6.5 Novartis Recent Development

11.7 Novo Nordisk

11.7.1 Novo Nordisk Company Detail

11.7.2 Novo Nordisk Business Overview

11.7.3 Novo Nordisk Anti-Diabetic Drugs Introduction

11.7.4 Novo Nordisk Revenue in Anti-Diabetic Drugs Business (2018-2023)

11.7.5 Novo Nordisk Recent Development

11.8 Sanofi

11.8.1 Sanofi Company Detail

11.8.2 Sanofi Business Overview

11.8.3 Sanofi Anti-Diabetic Drugs Introduction

11.8.4 Sanofi Revenue in Anti-Diabetic Drugs Business (2018-2023)

11.8.5 Sanofi Recent Development

11.9 Teva Pharmaceutical Industries

11.9.1 Teva Pharmaceutical Industries Company Detail

11.9.2 Teva Pharmaceutical Industries Business Overview

11.9.3 Teva Pharmaceutical Industries Anti-Diabetic Drugs Introduction

11.9.4 Teva Pharmaceutical Industries Revenue in Anti-Diabetic Drugs Business (2018-2023)

11.9.5 Teva Pharmaceutical Industries Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Anti-Diabetic Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Biguanides

    Table 3. Key Players of Sulfonylureas

    Table 4. Key Players of Meglitinides

    Table 5. Key Players of Thiazolidinediones

    Table 6. Key Players of Dipeptidyl Peptidase IV Inhibitors

    Table 7. Key Players of α-Glucosidase Inhibitors

    Table 8. Global Anti-Diabetic Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Anti-Diabetic Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 10. Global Anti-Diabetic Drugs Market Size by Region (2018-2023) & (US$ Million)

    Table 11. Global Anti-Diabetic Drugs Market Share by Region (2018-2023)

    Table 12. Global Anti-Diabetic Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 13. Global Anti-Diabetic Drugs Market Share by Region (2024-2029)

    Table 14. Anti-Diabetic Drugs Market Trends

    Table 15. Anti-Diabetic Drugs Market Drivers

    Table 16. Anti-Diabetic Drugs Market Challenges

    Table 17. Anti-Diabetic Drugs Market Restraints

    Table 18. Global Anti-Diabetic Drugs Revenue by Players (2018-2023) & (US$ Million)

    Table 19. Global Anti-Diabetic Drugs Market Share by Players (2018-2023)

    Table 20. Global Top Anti-Diabetic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Diabetic Drugs as of 2022)

    Table 21. Ranking of Global Top Anti-Diabetic Drugs Companies by Revenue (US$ Million) in 2022

    Table 22. Global 5 Largest Players Market Share by Anti-Diabetic Drugs Revenue (CR5 and HHI) & (2018-2023)

    Table 23. Key Players Headquarters and Area Served

    Table 24. Key Players Anti-Diabetic Drugs Product Solution and Service

    Table 25. Date of Enter into Anti-Diabetic Drugs Market

    Table 26. Mergers & Acquisitions, Expansion Plans

    Table 27. Global Anti-Diabetic Drugs Market Size by Type (2018-2023) & (US$ Million)

    Table 28. Global Anti-Diabetic Drugs Revenue Market Share by Type (2018-2023)

    Table 29. Global Anti-Diabetic Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 30. Global Anti-Diabetic Drugs Revenue Market Share by Type (2024-2029)

    Table 31. Global Anti-Diabetic Drugs Market Size by Application (2018-2023) & (US$ Million)

    Table 32. Global Anti-Diabetic Drugs Revenue Market Share by Application (2018-2023)

    Table 33. Global Anti-Diabetic Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 34. Global Anti-Diabetic Drugs Revenue Market Share by Application (2024-2029)

    Table 35. North America Anti-Diabetic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. North America Anti-Diabetic Drugs Market Size by Country (2018-2023) & (US$ Million)

    Table 37. North America Anti-Diabetic Drugs Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Europe Anti-Diabetic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Europe Anti-Diabetic Drugs Market Size by Country (2018-2023) & (US$ Million)

    Table 40. Europe Anti-Diabetic Drugs Market Size by Country (2024-2029) & (US$ Million)

    Table 41. Asia-Pacific Anti-Diabetic Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Asia-Pacific Anti-Diabetic Drugs Market Size by Region (2018-2023) & (US$ Million)

    Table 43. Asia-Pacific Anti-Diabetic Drugs Market Size by Region (2024-2029) & (US$ Million)

    Table 44. Latin America Anti-Diabetic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Latin America Anti-Diabetic Drugs Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Latin America Anti-Diabetic Drugs Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Middle East & Africa Anti-Diabetic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 48. Middle East & Africa Anti-Diabetic Drugs Market Size by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Anti-Diabetic Drugs Market Size by Country (2024-2029) & (US$ Million)

    Table 50. Astra Zeneca Company Detail

    Table 51. Astra Zeneca Business Overview

    Table 52. Astra Zeneca Anti-Diabetic Drugs Product

    Table 53. Astra Zeneca Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million)

    Table 54. Astra Zeneca Recent Development

    Table 55. Boehringer Ingelheim Company Detail

    Table 56. Boehringer Ingelheim Business Overview

    Table 57. Boehringer Ingelheim Anti-Diabetic Drugs Product

    Table 58. Boehringer Ingelheim Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million)

    Table 59. Boehringer Ingelheim Recent Development

    Table 60. Eli Lilly Company Detail

    Table 61. Eli Lilly Business Overview

    Table 62. Eli Lilly Anti-Diabetic Drugs Product

    Table 63. Eli Lilly Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million)

    Table 64. Eli Lilly Recent Development

    Table 65. Johnson & Johnson Company Detail

    Table 66. Johnson & Johnson Business Overview

    Table 67. Johnson & Johnson Anti-Diabetic Drugs Product

    Table 68. Johnson & Johnson Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million)

    Table 69. Johnson & Johnson Recent Development

    Table 70. Merck Company Detail

    Table 71. Merck Business Overview

    Table 72. Merck Anti-Diabetic Drugs Product

    Table 73. Merck Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million)

    Table 74. Merck Recent Development

    Table 75. Novartis Company Detail

    Table 76. Novartis Business Overview

    Table 77. Novartis Anti-Diabetic Drugs Product

    Table 78. Novartis Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million)

    Table 79. Novartis Recent Development

    Table 80. Novo Nordisk Company Detail

    Table 81. Novo Nordisk Business Overview

    Table 82. Novo Nordisk Anti-Diabetic Drugs Product

    Table 83. Novo Nordisk Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million)

    Table 84. Novo Nordisk Recent Development

    Table 85. Sanofi Company Detail

    Table 86. Sanofi Business Overview

    Table 87. Sanofi Anti-Diabetic Drugs Product

    Table 88. Sanofi Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million)

    Table 89. Sanofi Recent Development

    Table 90. Teva Pharmaceutical Industries Company Detail

    Table 91. Teva Pharmaceutical Industries Business Overview

    Table 92. Teva Pharmaceutical Industries Anti-Diabetic Drugs Product

    Table 93. Teva Pharmaceutical Industries Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million)

    Table 94. Teva Pharmaceutical Industries Recent Development

    Table 95. Research Programs/Design for This Report

    Table 96. Key Data Information from Secondary Sources

    Table 97. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Anti-Diabetic Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Anti-Diabetic Drugs Market Share by Type: 2022 VS 2029

    Figure 3. Biguanides Features

    Figure 4. Sulfonylureas Features

    Figure 5. Meglitinides Features

    Figure 6. Thiazolidinediones Features

    Figure 7. Dipeptidyl Peptidase IV Inhibitors Features

    Figure 8. α-Glucosidase Inhibitors Features

    Figure 9. Global Anti-Diabetic Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 10. Global Anti-Diabetic Drugs Market Share by Application: 2022 VS 2029

    Figure 11. Type I Diabetes Case Studies

    Figure 12. Type II Diabetes Case Studies

    Figure 13. Others Case Studies

    Figure 14. Anti-Diabetic Drugs Report Years Considered

    Figure 15. Global Anti-Diabetic Drugs Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 16. Global Anti-Diabetic Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 17. Global Anti-Diabetic Drugs Market Share by Region: 2022 VS 2029

    Figure 18. Global Anti-Diabetic Drugs Market Share by Players in 2022

    Figure 19. Global Top Anti-Diabetic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Diabetic Drugs as of 2022)

    Figure 20. The Top 10 and 5 Players Market Share by Anti-Diabetic Drugs Revenue in 2022

    Figure 21. North America Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. North America Anti-Diabetic Drugs Market Share by Country (2018-2029)

    Figure 23. United States Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Canada Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Europe Anti-Diabetic Drugs Market Share by Country (2018-2029)

    Figure 27. Germany Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. France Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. U.K. Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Italy Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Russia Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Nordic Countries Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Asia-Pacific Anti-Diabetic Drugs Market Share by Region (2018-2029)

    Figure 35. China Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Japan Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. South Korea Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Southeast Asia Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. India Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Australia Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Latin America Anti-Diabetic Drugs Market Share by Country (2018-2029)

    Figure 43. Mexico Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Brazil Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Middle East & Africa Anti-Diabetic Drugs Market Share by Country (2018-2029)

    Figure 47. Turkey Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Saudi Arabia Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Astra Zeneca Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023)

    Figure 50. Boehringer Ingelheim Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023)

    Figure 51. Eli Lilly Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023)

    Figure 52. Johnson & Johnson Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023)

    Figure 53. Merck Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023)

    Figure 54. Novartis Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023)

    Figure 55. Novo Nordisk Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023)

    Figure 56. Sanofi Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023)

    Figure 57. Teva Pharmaceutical Industries Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023)

    Figure 58. Bottom-up and Top-down Approaches for This Report

    Figure 59. Data Triangulation

    Figure 60. Key Executives Interviewed